A[Pharmaceutical sector’s rally expands Huaren Pharmaceutical and more than a dozen stocks hit their daily limit】On September 21, the pharmaceutical sector expanded its intraday gains, with innovative drugs and CRO continuing to lead the gains. Huaren Pharmaceutical rose to the daily limit of 20cm, and nearshore protein hit 20 cm hit the daily limit, reaching a record high. Previously, many stocks such as Yiyi Pharmaceutical, Novogene, Tojing Life, Harbin Sanlian, and Baihua Pharmaceuticals hit the daily limit, and Chengdu HitGen, New Ganjiang, Yahong Pharmaceutical, and Wanbang Pharmaceutical rose by more than 10%. B[AI pharmaceuticals and CRO concepts have repeatedly strengthened, and Novogene has reached a daily limit of 20cm] On September 21, AI pharmaceuticals and CRO concepts have repeatedly strengthened, and Novogene has reached a daily limit of 20cm. Hongbo Pharmaceuticals, Chengdu HitGen, Boji Pharmaceuticals, Berry Genetics, and Seli Medical followed suit. On the news, on September 18, ten departments including the Ministry of Industry and Information Technology jointly issued the "15th Five-Year Plan for the Development of the Pharmaceutical Industry." The plan proposes to accelerate the research and development of drugs enabled by new technologies such as artificial intelligence, quantum computing, supercomputing, and computational medicine, and explore new models of pharmaceutical and device production such as ultra-limited manufacturing, space pharmaceuticals, and biomanufacturing. B[AI pharmaceutical concept rebounded with shock and Chengdu Pioneer rose by more than 10%] On September 16th, the AI pharmaceutical concept rebounded with shock and rebound in the afternoon, with Chengdu Pioneer rising by more than 10%. Nearshore Protein, Kailer Shares, Medicilon, Hongbo Pharmaceutical, Boji Pharmaceutical, and Yaoshi Technology were among the top gainers. In terms of news, on September 14, the State Council Information Office held a press conference to introduce the decisive progress in promoting the construction of a healthy China. The National Health Commission proposed that attention should be paid to technological empowerment, especially the widespread application of artificial intelligence technology and biotechnology in the health field. A[CRO concept continues to adjust, Baihua Pharmaceutical drops by the limit] August 31st, the CRO concept continued last week's adjustment in early trading, Baihua Pharmaceutical fell by the limit, Purixisi, Wanbang Pharmaceutical fell more than 10%, CanSino, Nearshore Protein, Chengdu Pioneer, Yiqiao Shenzhou, etc. followed suit.
— All loaded —
